Travere Therapeutic (TVTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist

17.570
+0.070+0.40%

Close Nov 1 16:00 ET

17.570
0.0000.00%

Post 16:07 ET

1.37BMarket Cap-3836P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Travere Therapeutics Is Maintained at Sector Outperform by Scotiabank
Dow JonesNov 1 11:01 ET · Ratings
Travere Therapeutics Price Target Raised to $27.00/Share From $23.00 by Scotiabank
Dow JonesNov 1 11:01 ET · Ratings
Express News | Barclays Maintains Overweight on Travere Therapeutics, Raises Price Target to $20
BenzingaNov 1 10:07 ET
Travere Therapeutics Analyst Ratings
BenzingaNov 1 10:06 ET · Ratings
A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $20 to $33
Moomoo NewsNov 1 09:00 ET · Ratings
Travere Therapeutics, Inc. (TVTX) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsOct 31 15:13 ET

Comments

Stock_Drift

Oct 26 08:40

Earnings on 10/31 👻🎃

$Travere Therapeutic (TVTX.US)$

MMu

Oct 17 13:03

$Travere Therapeutic (TVTX.US)$ They got the europe approval as well! When is the next event date? @anyone

MMu

Oct 14 14:06

$Travere Therapeutic (TVTX.US)$
Someone buying large blocks 150k, 50k....
Does anybody know what's going on?

Jaguar8

Sep 26 15:03

NEWS

$Travere Therapeutic (TVTX.US)$
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). The voluntary enrollment pause enables the Company to work to address ...

Meltyy

Sep 10 04:37

📅 FDA PDUFA & AdCom Update…

📣 ITRM AdCom 9/9 meeting ongoing 🚗
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

TVTX Travere Therapeutic

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target